Neural prolotherapy, as developed by Jon Lyftogt, has been found to be an effective treatment for neurogenic pain syndromes. We report a case of trigeminal neuralgia successfully treated with neural prolotherapy. The patient is a 70-year-old man with a 15-year history of trigeminal neuralgia refractory to pharmacologic treatment. After one treatment of neural prolotherapy the patient reported 5 months of complete resolution of his symptoms. A second treatment was performed affording him another 10 months of relief. Neural prolotherapy may have an important role in treating trigeminal neuralgia. It can be a safe and effective treatment for those experiencing side effects from medications, contraindications to surgery, or less than favorable improvement from traditional treatments.
Mononeuralgia is pain along the distribution of a single peripheral nerve. Single nerve neuralgia is often caused by compression or other damage to the nerve, although in many cases a specific cause is not apparent. In instances where a structural cause is identified and corrected, patients may continue to experience pain in the affected nerve due to facilitation. This paper will discuss Neural Prolotherapy as a potential treatment for mononeuralgia by demonstrating cases of successful treatments for trigeminal neuralgia and meralgia paresthetica.
By Adam D. Weglein, DO, DABMA ABSTRACT There are many new developments in the world of regenerative Orthopedic Medicine. One innovative treatment option is called Neural Prolotherapy. Traditional Prolotherapy has focused on ligament-tendon healing, and has shown to be a powerful treatment modality. With Neural Prolotherapy, however we shift our focus to the subcutaneous nerves as more »